Trial Condition(s):

Magnetic Resonance Imaging, Image Enhancement

Drug Use Investigation of Gadovist.

Bayer Identifier:

17512

ClinicalTrials.gov Identifier:

NCT02540967

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The objectives of this study are to investigate the safety and effectiveness of Gadovist.

Inclusion Criteria
- Patients who perform contrast enhanced Magnetic Resonance Imaging (MRI) with Gadovist.
Exclusion Criteria
- Patients who are contraindicated based on approved label.

Trial Summary

Enrollment Goal
3357
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Gadavist/Gadovist (Gadobutrol, BAY86-4875)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Many Locations, Japan

Status
Completed
 

Trial Design